SCHEMBL2494893

SCHEMBL2494893

CCNC(=O)[C@@H]1CC(F)CN1C(=O)OCc1ccccc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.52
PRCP P42785 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.45
TSHR P16473 2/20 0.45
CYP3A4 P08684 1/20 0.45
MAPT P10636 1/20 0.45
CYP2C9 P11712 1/20 0.45
RAB9A P51151 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 1/20 0.45
LMNA P02545 1/20 0.45
PDK1 Q15118 1/20 0.44
PDK2 Q15119 1/20 0.44
PDK3 Q15120 1/20 0.44
PDK4 Q16654 1/20 0.44
HTR2C P28335 1/20 0.44
CFD P00746 1/20 0.44
NPSR1 Q6W5P4 2/20 0.43
ELANE P08246 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7038658 0.89 PRCP (0.57) POLBPRCPSMN1; SMN2TSHRCYP3A4
SCHEMBL6244596 0.89 PRCP (0.57) POLBPRCPSMN1; SMN2TSHRCYP3A4
SCHEMBL28461996 0.86 POLB (0.48) POLBPRCPSMN1; SMN2TSHRCYP3A4
SCHEMBL4245806 0.85 POLB (0.49) POLBSMN1; SMN2TSHRCYP3A4MAPT
SCHEMBL1336271 0.85 POLB (0.49) POLBSMN1; SMN2TSHRCYP3A4MAPT
SCHEMBL4245807 0.85 POLB (0.49) POLBSMN1; SMN2TSHRCYP3A4MAPT
SCHEMBL3788934 0.85 POLB (0.49) POLBSMN1; SMN2TSHRCYP3A4MAPT
SCHEMBL3784071 0.85 POLB (0.49) POLBSMN1; SMN2TSHRCYP3A4MAPT
SCHEMBL3793417 0.85 POLB (0.49) POLBSMN1; SMN2TSHRCYP3A4MAPT
SCHEMBL6167365 0.84 SMN1; SMN2 (0.51) POLBSMN1; SMN2RAB9AL3MBTL1PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8030499-B2 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2011-10-04 US disclosed
US-7528124-B2 1,3-dihydro-2H-indol-2-one derivative TAISHO PHARMACEUTICAL CO., LTD. (JP) 2009-05-05 US disclosed
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle TAISHO PHARMACEUTICAL CO., LTD. (JP) 2008-12-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080318923-A1 1,3-Dihydro-2H-Indole-2-One Compound and Pyrrolidine-2-One Compound Fused With Aromatic Heterocycle AVPR1B, AVPR1A, AVPR2 POLB 928/4885PRCP 2435/4885SMN1; SMN2 2982/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.